Research field (3)：
Medical systems
, Semiconductors, optical and atomic physics
, Urology
Research keywords (8)：
urothelial carcinoma
, Robotic surgery
, Laparoscopic surgery
, prostate carcinoma
, 前立腺肥大症
, sexual function
, Bladder endometriosis
, Endometriosis
Papers (169)：
Shunsuke Ikuma, Jun Akatsuka, Hikaru Mikami, Kotaro Obayashi, Yuki Endo, Hayato Takeda, Go Kimura, Yukihiro Kondo. Association between combination of VI-RADS based on T2WI and morphological features and pathological outcome and prognosis in bladder cancer. Journal of Clinical Oncology. 2025. 43. 5_suppl. 690-690
Hayato Takeda, Jun Akatsuka, Tomonari Kiriyama, Yuka Toyama, Yasushi Numata, Hiromu Morikawa, Kotaro Tsutsumi, Mami Takadate, Hiroya Hasegawa, Hikaru Mikami, et al. Clinically Significant Prostate Cancer Prediction Using Multimodal Deep Learning with Prostate-Specific Antigen Restriction. Current Oncology. 2024. 31. 11. 7180-7189
S. Ikuma, J. Akatsuka, H. Takeda, Y. Endo, T. Hamasaki, G. Kimura, Y. Kondo. O11 The quantification of morphological features of bladder cancer could improve diagnostic performance of VI-RADS and correlated to pathological features. European Urology Open Science. 2024. 69. 394-394
Masato Yanagi, Tomonari Kiriyama, Jun Akatsuka, Yuki Endo, Yuka Toyama, Go Kimura, Taiji Nishimura, Yukihiro Kondo. Role of collateral vessels on contrast-enhanced computed tomography in predicting metastatic potential for small renal cell carcinoma. Discover oncology. 2024. 15. 1. 523-523
S. Ikuma, J. Akatsuka, Y. Endo, H. Takeda, G. Kimura, Y. Kondo. 2004P The combination of high levels of serum cytokeratin fragment 21-1 and VI-RADS≧4 has diagnostic and prognostic value in high-stage bladder cancer. Annals of Oncology. 2024. 35. S1158-S1158
佐々木由香, 落合翔, 遠藤勇気, 鈴木康友, 近藤幸尋, 原俊太郎. Role of microsomal prostaglandin E synthase (mPGES)-1 in chemical-induced bladder cacrinogenesis. 日本薬学会年会要旨集(Web). 2024. 144th
Early switching to pembrolizumab during 1st -line platinum-based cytotoxic chemotherapy in patients with metastatic urothelial carcinoma
(ASCO-GU 2023 2023)
Prognostic impact of serum cytokeratin 19 fragments in patient with metastatic urothelial cancer treated with immune checkpoint inihibitors.
(ASCO-GU 2022 (American Society of Clinical Oncology Genitourinary Cancers Symposium) 2022)
Prognostic impact of serum cytokeratin 19 fragments in patient with metastatic urothelial cancer (mUC) treated with first-line chemotherapy
(ASCO-GU 2021 (American Society of Clinical Oncology Genitourinary Cancers Symposium) 2021)
Can serum cytokeratin 19 fragments predict postoperative early progression in patients with upper urinary tract urothelial carcinoma?
(ASCO-GU 2020 (American Society of Clinical Oncology Genitourinary Cancers Symposium) 2020)
Early clinical outcomes of transurethral enucleation with bipolar compared with transurethral resection in saline for Benign Prostatic Hyperplasia treatment.
(World Congress of Endourology @Abu Dhabi 2019)
Efficacy of Laparoscopic Partial Cystectomy with a Transurethral Resectoscope in Patients with Bladder Endometriosis: See-Through Technique (Nippon Medical School)
Work history (6)：
2022/10 - 現在 Nippon Medical School Department of Urology Senior Lecturer
2018/10 - 2022/09 Nippon Medical School Department of Urology Assistant professor
2017/02 - 2018/09 Kitamurayama Hospital Department of Urology Medical director
2014/04 - 2017/01 Nippon Medical School Hospital Department of Urology assistant professor
2011/04 - 2014/03 Nasu Red Cross Hospital Department of Urology Vice director of Urology
2010/04 - 2011/03 Chibaken Saiseikai Narashino Hospital Department of Urology Doctor
Show all
Association Membership(s) (8)：
Japan Anti-aging
, Japan Continence Society
, JAPANESE SOCIETY FOR SEXUAL MEDICINE
, JAPANESE SOCIETY OF ENDOUROLOGY
, 日本がん治療学会
, JAPAN SOCIETY OF UROLOGIC ONCOLOGY
, JAPANESE SOCIETY FOR ENDOSCOPIC SURGERY
, THE JAPANESE UROLOGICAL ASSOCIATION
